Akcea Therapeutics, Inc. Operating Lease Cost
Akcea Therapeutics, Inc. reported Operating Lease Cost of $2.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2020-03-02
- Akcea Therapeutics, Inc. operating lease, cost for the quarter ending 2019-12-31 was $500.00K, a 28.57% decline year-over-year.
- Akcea Therapeutics, Inc. operating lease, cost for the quarter ending 2019-09-30 was $500.00K, a 37.50% decline year-over-year.
- Akcea Therapeutics, Inc. operating lease, cost for the quarter ending 2019-06-30 was $500.00K, a 28.57% decline year-over-year.
- Akcea Therapeutics, Inc. operating lease, cost for the quarter ending 2019-03-31 was $500.00K, a 150.00% increase year-over-year.
- Akcea Therapeutics, Inc. operating lease, cost for fiscal 2019 was $2.10M, a 12.50% decline from fiscal 2018.
- Akcea Therapeutics, Inc. operating lease, cost for fiscal 2018 was $2.40M, a 242.86% increase from fiscal 2017.
- Akcea Therapeutics, Inc. operating lease, cost for fiscal 2017 was $700.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.00M derived: sum of 2 quarters · filed 2020-03-02 | $1.50M derived: sum of 3 quarters · filed 2020-03-02 | $2.10M 10-K · filed 2020-03-02 |
| 2019-09-30 | $500.00K 10-Q · filed 2019-11-06 | $1.00M derived: sum of 2 quarters · filed 2019-11-06 | $1.60M 10-Q · filed 2019-11-06 | $2.20M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-06-30 | $500.00K 10-Q · filed 2019-08-07 | $1.10M 10-Q · filed 2019-08-07 | $1.70M derived: sum of 3 quarters · filed 2020-03-02 | $2.50M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-09 | $1.20M derived: sum of 2 quarters · filed 2020-03-02 | $2.00M derived: sum of 3 quarters · filed 2020-03-02 | $2.70M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.50M derived: sum of 2 quarters · filed 2020-03-02 | $2.20M derived: sum of 3 quarters · filed 2020-03-02 | $2.40M 10-K · filed 2020-03-02 |
| 2018-09-30 | $800.00K 10-Q · filed 2019-11-06 | $1.50M derived: sum of 2 quarters · filed 2019-11-06 | $1.70M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $700.00K 10-Q · filed 2019-08-07 | $900.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $700.00K 10-K · filed 2020-03-02 |